10 more years
Martinsried – Antibody specialist MorphoSys AG deals successfully with it’s partnerships: Novartis has committed to a ten-year term of the strategic alliance originally signed in December 2007. The decision was based on the successful achievement of certain predefined improvements in its proprietary technologies. The collaboration will now run until 2017 and may be extended by Novartis for an additional two years beyond that time under the same financial terms and conditions, which include committed payments in excess of US$600m over the ten-year lifetime. The option for Novartis to terminate the alliance after seven years is thereby removed.